Stocks in Focus

TONGYANG PILE, Inc. Hits Daily Price Limit as Disaster Safety Theme Gains Momentum… Expected to Benefit from Earthquake-Resistant Infrastructure [Featured Stock]

Kim Hyung-il
2026-09-02 10:36:41
[Edaily Reporter Kim Hyung-il ] TONGYANG PILE, Inc.(228340), a company specializing in concrete piles for foundation reinforcement, hit the daily price limit as it gained attention as a stock related to disaster safety and earthquake-resistant infrastructure.

TONGYANG PILE, Inc. CI. (Photo: TONGYANG PILE, Inc.)


According to MP Doctor on the 2nd, as of 10:28 a.m., TONGYANG PILE, Inc. was trading at 3,885 won, up 895 won (29.93%) from the previous trading day. The stock reached the daily price limit around 10:10 a.m. and has remained there since.

No specific announcements regarding TONGYANG PILE, Inc. were made today. This is interpreted as buying interest flowing into infrastructure companies—such as those specializing in earthquake-resistant materials and ground reinforcement—amid growing public concern over disaster prevention and building safety.

TONGYANG PILE, Inc. is a construction materials company whose core business is the manufacture and sale of concrete piles. Its main product, high-strength concrete piles (PHC), is used to reinforce the ground and support structures during foundation work for buildings. Market analysts are also pointing to the potential for the company to benefit from expanded investment in earthquake-resistant design and ground reinforcement infrastructure.

Earnings have also improved. TONGYANG PILE, Inc.’s second-quarter revenue this year reached approximately 20.676 billion won, an increase from the previous quarter, and the company posted a profit with an operating profit of 2.344 billion won and a net income of 2.43 billion won.

Economy

Corporation

IT·Science

Economy

Jay Y. Lee Visits His Father’s Grave Immediately After Returning from the UAE… Commemorating the 6th Anniversary of Lee Kun-Hee’s Passing

On the sixth anniversary of the passing of the late Lee Kun-Hee, former chairman of SamsungElectronics, Jay Y. Lee and executives from major affiliate companies gathered at the family cemetery in Suwo…
2026-10-23 10:34:32

Corporation

Is the Efficacy Announcement a “Predetermined Outcome”?… “Some Indicators Point in the Desired Direction”

Aptabio Therapeutics Inc.(293780)has expressed confidence ahead of the announcement of the efficacy of its kidney disease treatment candidate “Isuzinaxib” (APX-115). This follows the company’s selecti…
2026-10-23 12:02:02

IT·Science

Orum Therapeutics, Inc. Welcomes U.S. BD Expert Back to Board… A Breakthrough After BMS?

#Orum Therapeutics, Inc. has reappointed a U.S. business development (BD) expert to its board of directors and expanded the limit on stock options granted to U.S. employees. At an investor briefing he…
2026-10-23 11:29:02